Published on 23 Dec 2023 on GuruFocus.com via Yahoo Finance
On December 22, 2023, Martina Flammer, the Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 28,310 shares of the company's stock, according to a recent SEC Filing. The transaction was executed with the stock priced at $30 per share, resulting in a total sale amount of $849,300.
Warning! GuruFocus has detected 5 Warning Signs with INSM.
Insmed Incorporated is a global biopharmaceutical company focused on the development and commercialization of therapies for patients with serious and rare diseases. The company's products are designed to address unmet medical needs, particularly in the areas of lung and infectious diseases.